Paris, France, New York, USA, Sept. 17, 2026
(GLOBE NEWSWIRE)
--
Dr Grasso brings more than 28 years of public company, capital markets, and investment banking management experience
Continues Cyllene Tx’s strategic business and clinical development growth in the US
Paris, France and New York, USA, September 17, 2026 –
Cyllene Therapeutics (“Cyllene Tx”), the global leader in non-systemic, site-specific therapies for neurological disorders, today announced the appointment of Marc Grasso, MD,